Lupin shuts manufacturing plant after 17 staff test Covid-19 positive

The firm has some 11 manufacturing plants at the Ankleshwar site in Gujarat state, which is spread out over 40 acres and has 984 employees, according to the company website.

Lupin
Employees from one of the plants, which produces tuberculosis drugs, have tested positive in recent days.
Reuters
1 min read Last Updated : Jul 14 2020 | 11:34 PM IST
Drugmaker Lupin has shut one of its manufacturing plants in Gujarat after at least 17 employees at the site tested positive for Covid-19, two government officials said on Tuesday.

Lupin, one of India’s top five drugmakers, did not immediately respond to requests for comment. The firm has some 11 manufacturing plants at the Ankleshwar site in Gujarat state, which is spread out over 40 acres and has 984 employees, according to the company website.

Employees from one of those plants, which produces tuberculosis drugs, have tested positive in recent days, said M D Modia, a senior district official. “The plant was shut on July 12 after the cases were confirmed,” said Modia, adding that the site has since been sanitized. “No cases have been reported from the other plants in the facility and their operations are unaffected,” he said. 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusLockdownLupinPharma CompaniesGujarat

Next Story